STOCK TITAN

Tactile Systems Technology Inc - TCMD STOCK NEWS

Welcome to our dedicated news page for Tactile Systems Technology (Ticker: TCMD), a resource for investors and traders seeking the latest updates and insights on Tactile Systems Technology.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Tactile Systems Technology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Tactile Systems Technology's position in the market.

Rhea-AI Summary
Tactile Systems Technology, Inc. reported an 11% increase in full-year revenue, with net income up by 260% and adjusted EBITDA up by 62%. The company treated over 77,000 patients and introduced new products in 2023. Full-year revenue reached $274.4 million, with a net income of $28.5 million. The company aims for 2024 revenue of $300-305 million, expecting 9-11% growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.2%
Tags
earnings
-
Rhea-AI Summary
Tactile Systems Technology, Inc. announces participation in upcoming investor conferences. The company will be present at the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference and the Oppenheimer 34th Annual Healthcare MedTech & Services Conference. Management will participate in investor meetings and a virtual fireside chat to discuss the company's medical technology and therapies for chronic disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags
conferences
-
Rhea-AI Summary
Tactile Medical, a medical technology company, will release its fourth quarter and fiscal year 2023 financial results on February 20th. The company will host a conference call to discuss the results, and a live webcast will be available on the investor relations section of the Company's website. Those interested in participating can dial in or access the webcast. A replay will also be available for two weeks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.34%
Tags
earnings
Rhea-AI Summary
Tactile Medical, a medical technology company, reported Q3 2023 financial results. Revenue increased 7% YoY to $69.6 million. Lymphedema revenue increased 15%, while airway clearance revenue decreased 36%. Operating income was $8.0 million, compared to an operating loss of $1.6 million in Q3 2022. Net income was $22.3 million, compared to a net loss of $2.3 million in Q3 2022. The company's cash balance was $66.0 million on September 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.22%
Tags
earnings
-
Rhea-AI Summary
Tactile Medical to release Q3 2023 financial results on Nov 6 and host conference call at 5:00 p.m. ET
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.95%
Tags
earnings
-
Rhea-AI Summary
Tactile Medical appoints Dr. Vindell Washington to its Board of Directors, bringing over 30 years of healthcare industry experience. Dr. Washington is recognized as one of the Most Influential Minority Executives in Healthcare. He has expertise in advising healthcare companies and has held leadership positions at Verily, Blue Cross Blue Shield of Louisiana, and the U.S. Department of Health and Human Services. His appointment is expected to bring valuable insights and guidance to Tactile Medical.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
management
Rhea-AI Summary
Tactile Medical to participate in upcoming investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.02%
Tags
conferences
-
Rhea-AI Summary
Tactile Medical to participate in Wells Fargo Healthcare Conference on September 7th.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
conferences
-
Rhea-AI Summary
Tactile Medical reports Q2 2023 financial results, with revenue increasing 15% YoY to $68.3M. Operating income of $2.1M compared to operating loss of $4.1M. Net loss of $0.1M compared to net loss of $4.6M. Adjusted EBITDA of $6.1M, up from $1.7M. Cash balance of $63.1M on June 30, 2023, compared to $55M on March 31, 2023. Raised full year 2023 financial guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.82%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.57%
Tags
management
Tactile Systems Technology Inc

Nasdaq:TCMD

TCMD Rankings

TCMD Stock Data

383.51M
21.62M
1.98%
91.44%
6.23%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Minneapolis

About TCMD

tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.